Similar to the current study, we previously assessed the possible relationship between FGF23 (or α-Klotho) and cardiac hypertrophy and systolic dysfunction among patients admitted to the cardiology department, although the study population was much smaller [16]. This evidence concerns the gene FGF23 and cardiac hypertrophy.